{"id":"tp-58400","type":"article-newspaper","title":"Eloxx Pharmaceuticals Posts $0.49 Q3 GAAP Loss Per Share, Beats Estimate","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58400","datePublished":"2026-11-16T13:44:13.000Z","dateModified":"2026-11-16T13:44:13.000Z","language":"en","abstract":"Cash and cash equivalents were $56.3 million on Sept. 30, down from $62 million on June 30. The company said it believes its cash can fund operations into 2028.","section":"Business","references":[]}